Antiretroviral Therapy for Prevention of Human Immunodeficiency Virus Infection.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 27235622.
- Also identified by DOI 10.1016/j.mcna.2016.03.013.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Human immunodeficiency virus (HIV) infection is considered a chronic medical condition. Several new drugs are available, including fixed-dose combination tablets, that have greatly simplified combination antiretroviral therapy (ART) regimens to treat HIV, while increasing the life-expectancy of infected individuals. In the last decade, multiple well-regarded studies have established the benefits of using ART in high-risk, HIV-negative persons to prevent HIV acquisition. The primary care provider must not only understand commonly encountered issues pertaining to ART, such as toxicities and drug interactions, but also needs to be aware of using ART for HIV prevention.
Medical subject headings
- Anti-Retroviral Agents
- HIV Infections
- Infectious Disease Transmission, Vertical
- Post-Exposure Prophylaxis
- Pre-Exposure Prophylaxis